Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Tempest Therapeutics
(NASDAQ:TPST)
Intraday
$3.45
0.01
[0.29%]
After-Hours
$3.45
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$3.45
0.01
[0.29%]
At close: Apr 25
$3.45
0
[0.00%]
After Hours: 7:57PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Tempest Therapeutics Stock (NASDAQ:TPST)
Tempest Therapeutics Stock (NASDAQ: TPST)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 05, 2024
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Apr 5, 2024, 1:06PM
Thursday, April 04, 2024
Tempest Announces Publication Of Data From Phase 1 Trial Of TPST-1120 In Patients With Advanced Solid Tumors In Journal Of Cancer Research Communications
Benzinga Newsdesk
-
Apr 4, 2024, 8:10AM
Wednesday, March 20, 2024
HC Wainwright & Co. Reiterates Buy on Tempest Therapeutics, Maintains $47 Price Target
Benzinga Newsdesk
-
Mar 20, 2024, 6:39AM
Tuesday, March 19, 2024
Tempest FY23 EPS $(1.91) Vs $(3.09) YoY; Ended The Year With $39.2M In Cash And Cash Equivalents
Happy Mohamed
-
Mar 19, 2024, 4:40PM
Thursday, March 14, 2024
Scotiabank Initiates Coverage On Tempest Therapeutics with Sector Outperform Rating, Announces Price Target of $13
Benzinga Newsdesk
-
Mar 14, 2024, 5:40AM
Wednesday, March 13, 2024
Scotiabank Initiates Coverage On Tempest Therapeutics with Sector Outperform Rating, Announces Price Target of $13
Benzinga Newsdesk
-
Mar 13, 2024, 5:24PM
Tuesday, March 12, 2024
HC Wainwright & Co. Maintains Buy on Tempest Therapeutics, Maintains $47 Price Target
Benzinga Newsdesk
-
Mar 12, 2024, 11:01AM
Tempest Presents New Data At The SITC 2024 Spring Scientific Meeting Supporting Potent Anti-Tumor Activity Of TPST-1120 In Multiple Cancer Types
Happy Mohamed
-
Mar 12, 2024, 8:15AM
Tuesday, March 05, 2024
Tempest Announces Upcoming Presentation Of Preclinical Data For TPST-1120 In Renal Cell Carcinoma At AACR Annual Meeting
Benzinga Newsdesk
-
Mar 5, 2024, 4:36PM
Thursday, February 08, 2024
Jefferies Initiates Coverage On Tempest Therapeutics with Buy Rating, Announces Price Target of $15
Benzinga Newsdesk
-
Feb 8, 2024, 7:46AM
Tuesday, January 30, 2024
Tempest Therapeutics Shares Up 19% Premarket. A Press Release Earlier Announced A Presentation On Its Liver Cancer Treatment At ASCO Annual Meeting 2024
Charles Gross
-
Jan 30, 2024, 6:51AM
Tempest Therapeutics Announces Advances In Liver Cancer Treatment, Showcasing Exceptional Efficacy And Safety Data At ASCO Annual Meeting 2024
Benzinga Newsdesk
-
Jan 30, 2024, 2:23AM
Tuesday, January 16, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
Jan 16, 2024, 12:35PM
Thursday, November 09, 2023
Tempest Therapeutics shares are trading higher. The company reported Q3 financial results.
Benzinga Newsdesk
-
Nov 9, 2023, 2:04PM
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 9, 2023, 1:13PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Nov 9, 2023, 12:31PM
Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings
Lisa Levin
-
Nov 9, 2023, 12:01PM
Wednesday, November 08, 2023
Tempest Q3 EPS $(0.48); Cash And Equivalents At End Of Q3 $11.1M
Benzinga Newsdesk
-
Nov 8, 2023, 5:35PM
Tuesday, October 31, 2023
Biggest Short Squeeze Stocks Of The Week: Two Biotech Stocks Move Up To Top The List
Chris Katje
-
Oct 31, 2023, 10:21AM
Monday, October 30, 2023
On October 26, 2023, Tempest Therapeutics Received A Formal Notification From The Nasdaq That The Company Has Regained Compliance With Nasdaq $1.00 Minimum Price Rule
Charles Gross
-
Oct 30, 2023, 6:10AM
Tuesday, October 24, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Oct 24, 2023, 1:31PM
Wednesday, October 18, 2023
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 18, 2023, 2:15PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Oct 18, 2023, 9:06AM
Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 18, 2023, 8:18AM
Tuesday, October 17, 2023
What's Going On With Tempest Therapeutics Stock Today?
Erica Kollmann
-
Oct 17, 2023, 11:18AM
Tempest Therapeutics Shares Resume Trade
Benzinga Newsdesk
-
Oct 17, 2023, 9:49AM
Tempest Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 1.93%
Benzinga Newsdesk
-
Oct 17, 2023, 9:47AM
Monday, October 16, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Oct 16, 2023, 1:31PM
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 16, 2023, 1:09PM
Tempest Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 66.5%
Benzinga Newsdesk
-
Oct 16, 2023, 10:57AM
MAIA Biotechnology's THIO Emerges As Potential Breakthrough In Pediatric Brain Cancer Therapy
Jeremy Golden
-
Oct 16, 2023, 8:11AM
Friday, October 13, 2023
Tempest Therapeutics Shares Resumed Trade
Benzinga Newsdesk
-
Oct 13, 2023, 12:39PM
Tempest Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 23.9%
Benzinga Newsdesk
-
Oct 13, 2023, 12:30PM
Thursday, October 12, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Oct 12, 2023, 5:31PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Oct 12, 2023, 1:37PM
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Oct 12, 2023, 12:55PM
Tempest Therapeutics Shares Resume Trading
Benzinga Newsdesk
-
Oct 12, 2023, 9:48AM
US Stocks Edge Lower; Consumer Price Index Increases 0.4% For September
Lisa Levin
-
Oct 12, 2023, 9:46AM
Tempest Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Down -42%
Benzinga Newsdesk
-
Oct 12, 2023, 9:45AM
Tempest Therapeutics Shares Resume Trade
Benzinga Newsdesk
-
Oct 12, 2023, 9:42AM
Tempest Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Down -37.9%
Benzinga Newsdesk
-
Oct 12, 2023, 9:33AM
Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Oct 12, 2023, 9:29AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Oct 12, 2023, 9:06AM
What's Going On With Tempest Therapeutics Stock?
Adam Eckert
-
Oct 12, 2023, 8:56AM
Wednesday, October 11, 2023
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro
-
Oct 11, 2023, 10:16PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Oct 11, 2023, 5:32PM
Crude Oil Down 2.5%; Silk Road Medical Shares Plummet
Lisa Levin
-
Oct 11, 2023, 2:52PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Oct 11, 2023, 1:31PM
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Oct 11, 2023, 1:13PM
Dow Turns Lower; Tempest Therapeutics Shares Spike Higher
Lisa Levin
-
Oct 11, 2023, 12:38PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch